We are live on ! Find out more
CTMX icon

CytomX Therapeutics
CTMX

48 hedge funds and large institutions have $360M invested in CytomX Therapeutics in 2015 Q4 according to their latest regulatory filings, with 48 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
48
Holders Change
+48
Holders Change %
–
% of All Funds
1.26%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.08%
New
48
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$85.5M
2
DM
Deerfield Management
New York
+$15M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$11.9M
4
RG
Redmile Group
California
+$11.7M
5
PA
Perceptive Advisors
New York
+$10.2M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
26
Susquehanna International Group
Pennsylvania
$485K +$367K +23,222 New
Charles Schwab
27
Charles Schwab
California
$472K +$357K +22,571 New
D.E. Shaw & Co
28
D.E. Shaw & Co
New York
$444K +$336K +21,257 New
Bank of New York Mellon
29
Bank of New York Mellon
New York
$382K +$289K +18,285 New
TCIM
30
TIAA CREF Investment Management
New York
$359K +$272K +17,210 New
Goldman Sachs
31
Goldman Sachs
New York
$319K +$242K +15,278 New
QSS
32
Quantitative Systematic Strategies
Florida
$300K +$228K +14,409 New
California State Teachers Retirement System (CalSTRS)
33
California State Teachers Retirement System (CalSTRS)
California
$296K +$225K +14,200 New
CS
34
Candriam SCA
Luxembourg
$209K +$158K +10,000 New
TA
35
Teachers Advisors
New York
$160K +$121K +7,663 New
Morgan Stanley
36
Morgan Stanley
New York
$123K +$93.4K +5,902 New
NFA
37
Nationwide Fund Advisors
Ohio
$96K +$73K +4,613 New
BA
38
BlackRock Advisors
Delaware
$53K +$40.3K +2,550 New
SO
39
STRS Ohio
Ohio
$52K +$39.6K +2,500 New
Citigroup
40
Citigroup
New York
$48K +$36.6K +2,312 New
Wells Fargo
41
Wells Fargo
California
$47K +$35.4K +2,235 New
Bank of America
42
Bank of America
North Carolina
$42K +$31.7K +2,006 New
Deutsche Bank
43
Deutsche Bank
Germany
$39K +$30.5K +1,928 New
BNP Paribas Financial Markets
44
BNP Paribas Financial Markets
France
$28.7K +$21.8K +1,376 New
TRCT
45
Tower Research Capital (TRC)
New York
$25K +$19.3K +1,219 New
Fifth Third Bancorp
46
Fifth Third Bancorp
Ohio
$15K +$11.7K +740 New
UBS Group
47
UBS Group
Switzerland
$14K +$10.5K +664 New
Barclays
48
Barclays
United Kingdom
$3K +$2.64K +167 New
1
2

CTMX Hedge Fund Activity: Q4 2015 in Review

48 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in CytomX Therapeutics (CTMX) for Q4 2015, worth a combined $360M.

Buyers outnumbered sellers: 48 funds opened new CTMX positions and 0 closed out — a net gain of 48 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $85.5M.

  • 48 institutional investors held CytomX Therapeutics (CTMX) as of Q4 2015, up from 0 in Q3 2015.
  • Funds reported $360M of CytomX Therapeutics stock for Q4 2015.
  • 48 funds opened new CytomX Therapeutics positions in Q4 2015 and 0 closed out, a net change of +48 holders.
  • The largest CytomX Therapeutics buyer in Q4 2015 was Fidelity Investments, an estimated $85.5M added.

Based on aggregated 13F filings for Q4 2015.